211 related articles for article (PubMed ID: 23449915)
1. An overview of the surgical management of hepatic neuroendocrine metastases.
Pathak S; Dash I; Taylor MR; Poston GJ
Indian J Surg Oncol; 2012 Mar; 3(1):20-5. PubMed ID: 23449915
[TBL] [Abstract][Full Text] [Related]
2. The surgical management of neuroendocrine tumour hepatic metastases.
Pathak S; Dash I; Taylor MR; Poston GJ
Eur J Surg Oncol; 2013 Mar; 39(3):224-8. PubMed ID: 23290582
[TBL] [Abstract][Full Text] [Related]
3. Hepatic surgery for metastases from neuroendocrine tumors.
Sarmiento JM; Que FG
Surg Oncol Clin N Am; 2003 Jan; 12(1):231-42. PubMed ID: 12735141
[TBL] [Abstract][Full Text] [Related]
4. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].
Auernhammer CJ; Jauch KW; Hoffmann JN
Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic strategies for neuroendocrine liver metastases.
Frilling A; Clift AK
Cancer; 2015 Apr; 121(8):1172-86. PubMed ID: 25274401
[TBL] [Abstract][Full Text] [Related]
6. Curative versus palliative surgical resection of liver metastases in patients with neuroendocrine tumors: a meta-analysis of observational studies.
Bacchetti S; Pasqual EM; Bertozzi S; Londero AP; Risaliti A
Gland Surg; 2014 Nov; 3(4):243-51. PubMed ID: 25493256
[TBL] [Abstract][Full Text] [Related]
7. Hepatic resection for metastatic gastrointestinal and pancreatic neuroendocrine tumours: outcome and prognostic predictors.
Gomez D; Malik HZ; Al-Mukthar A; Menon KV; Toogood GJ; Lodge JP; Prasad KR
HPB (Oxford); 2007; 9(5):345-51. PubMed ID: 18345317
[TBL] [Abstract][Full Text] [Related]
8. Surgical Approaches to the Management of Neuroendocrine Liver Metastases.
Frilling A; Clift AK
Endocrinol Metab Clin North Am; 2018 Sep; 47(3):627-643. PubMed ID: 30098720
[TBL] [Abstract][Full Text] [Related]
9. Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review.
Harring TR; Nguyen NT; Goss JA; O'Mahony CA
Int J Hepatol; 2011; 2011():154541. PubMed ID: 22013537
[TBL] [Abstract][Full Text] [Related]
10. Palliative cytoreductive surgery versus other palliative treatments in patients with unresectable liver metastases from gastro-entero-pancreatic neuroendocrine tumours.
Gurusamy KS; Pamecha V; Sharma D; Davidson BR
Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD007118. PubMed ID: 19160322
[TBL] [Abstract][Full Text] [Related]
11. The role of cytoreductive hepatic surgery as an adjunct to the management of metastatic neuroendocrine carcinomas.
Hodul P; Malafa M; Choi J; Kvols L
Cancer Control; 2006 Jan; 13(1):61-71. PubMed ID: 16508628
[TBL] [Abstract][Full Text] [Related]
12. Defining a New Classification System for the Surgical Management of Neuroendocrine Tumor Liver Metastases.
Mahuron KM; Singh G
J Clin Med; 2023 Mar; 12(7):. PubMed ID: 37048539
[TBL] [Abstract][Full Text] [Related]
13. Multimodal management of neuroendocrine liver metastases.
Frilling A; Sotiropoulos GC; Li J; Kornasiewicz O; Plöckinger U
HPB (Oxford); 2010 Aug; 12(6):361-79. PubMed ID: 20662787
[TBL] [Abstract][Full Text] [Related]
14. Treatment of liver metastases in patients with neuroendocrine tumors.
Frilling A; Rogiers X; Malagó M; Liedke OM; Kaun M; Broelsch CE
Langenbecks Arch Surg; 1998 Mar; 383(1):62-70. PubMed ID: 9627173
[TBL] [Abstract][Full Text] [Related]
15. Surgical management of recurrent colon cancer.
Brown KGM; Koh CE
J Gastrointest Oncol; 2020 Jun; 11(3):513-525. PubMed ID: 32655930
[TBL] [Abstract][Full Text] [Related]
16. Hepatic micrometastases outside macrometastases are present in all patients with ileal neuroendocrine primary tumour at the time of liver resection.
Fossmark R; Balto TM; Martinsen TC; Grønbech JE; Munkvold B; Mjønes PG; Waldum HL
Scand J Gastroenterol; 2019 Aug; 54(8):1003-1007. PubMed ID: 31368380
[No Abstract] [Full Text] [Related]
17. Primary tumour resection may improve survival in functional well-differentiated neuroendocrine tumours metastatic to the liver.
Citterio D; Pusceddu S; Facciorusso A; Coppa J; Milione M; Buzzoni R; Bongini M; deBraud F; Mazzaferro V
Eur J Surg Oncol; 2017 Feb; 43(2):380-387. PubMed ID: 27956320
[TBL] [Abstract][Full Text] [Related]
18. Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques.
Atwell TD; Charboneau JW; Que FG; Rubin J; Lewis BD; Nagorney DM; Callstrom MR; Farrell MA; Pitot HC; Hobday TJ
Cardiovasc Intervent Radiol; 2005; 28(4):409-21. PubMed ID: 16041556
[TBL] [Abstract][Full Text] [Related]
19. Liver transplantation for the treatment of neuroendocrine liver metastases.
Vilchez V; Gedaly R
Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):141-7. PubMed ID: 26971850
[TBL] [Abstract][Full Text] [Related]
20. Current Management of Neuroendocrine Tumour Liver Metastases.
Sharma A; Muralitharan M; Ramage J; Clement D; Menon K; Srinivasan P; Elmasry M; Reed N; Seager M; Srirajaskanthan R
Curr Oncol Rep; 2024 Jun; ():. PubMed ID: 38869667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
